Stay updated on Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page
- Check6 days agoChange DetectedA new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed. The page now includes newly added References and Study Status entries in the Record History.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision v3.4.2 was added to the history, and the funding lapse notice and prior Revision: v3.4.1 were removed as administrative updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check41 days agoChange DetectedA site-wide notice about government funding delays was added and the site version label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedRecord History and Study Record Versions were added, along with Results Posted, Researcher View, Save, and Download options, and color-coded indicators now show additions and deletions across versions.SummaryDifference35%

- Check62 days agoChange DetectedThe history now includes a new Revision: v3.3.4 and the previous Revision: v3.3.3 is removed.SummaryDifference0.1%

- Check84 days agoChange DetectedThe history shows a new revision entry 'Revision: v3.3.3' added and previous entries 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' removed in the page's version list; these are non-content site maintenance updates, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page.